Journal Mobile Options
Table of Contents
Vol. 104, No. 2-3, 2000
Issue release date: January 2001
Acta Haematol 2000;104:106–109
(DOI:10.1159/000039761)

Scleroderma Associated with Anemia and Thrombocytopenia that Responded Well to Cyclosporin

Kamada K. · Kobayashi Y. · Katada K. · Takahashi Y. · Chikayama S. · Ikeda M. · Kondo M.
First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

A 55-year-old woman came to our hospital because of cutaneous sclerosis of the limbs in September 1996, and was diagnosed with scleroderma based on a skin biopsy. In August 1997, the cutaneous sclerosis became progressive (hemoglobin level, 4.3 g/dl; platelet count, 7 × 109/l). The laboratory results were positive for the direct Coombs test, bone marrow aspiration showed a dry tap, and the bone marrow biopsy showed marked fatty marrow. Indium-111 bone marrow scintigraphy showed a markedly decreasing uptake. These findings indicated bone marrow hypoplasia associated with hemolytic anemia. After prednisolone therapy (60 mg) was initiated, the direct Coombs test became negative but the blood cell count did not increase. Then, 300 mg of cyclosporin was initiated and anemia and thrombocytopenia improved. The cyclosporin dosage was gradually decreased and the patient’s hematological condition was good, although the cutaneous sclerosis changed only a little. This is a rare and interesting case of a patient with scleroderma associated with bone marrow insufficiency and hemolysis who responded well to cyclosporin.

Copyright © 2001 S. Karger AG, Basel



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Doyle JA, Connolly SM, Hoagland HC: Hematologic disease in scleroderma syndromes. Acta Derm Venereol 1985;65:521–525.

    External Resources

  2. Westerman MP, Martinez RC, Medsger AT, Totten RS, Rodnan GP: Anemia and scleroderma. Arch Intern Med 1962;122:39–42.

    External Resources

  3. Tooze JA, Marsh NW, Duke OL, Behrens J, Gordon-Smith EC: Response of aplastic anemia and scleroderma to cyclosporin. Br J Haematol 1993;85:829–831.
  4. Carcassonne Y, Gastaut JA: Pancytopenia and scleroderma. Br Med J 1976;12:1446.
  5. Bonati A, Aielli F, Carnevali C: A case of scleroderma associated with total medullary aplasia (in Italian). Ateneo Parmense Acta Biomed 1977;48:499–504.

    External Resources

  6. Balaban EP, Sheehan RG, Lipsky PE, Frenkel FP: Treatment of cutaneous sclerosis and aplastic anemia with antithymocyte globulin. Ann Intern Med 1987;106:56–58.

    External Resources

  7. Fenaux P, Merignargues S, Pagniez D, Janin A, Lucidarme D, Bauters F: Cutaneous sclerosis, aplastic anemia, and antithymocyte globulin. Ann Intern Med 1989;110:575–576.
  8. Ohe A, Amatsu K, Okamura M, Katoh N, Kanayama Y, Horiguchi T, Kohno M, Fujimoto S, Inoue T: A case of scleroderma associated with pancytopenia (in Japanese). Nippon Naika Gakkai Zasshi 1982;71:1747–1749.
  9. Matsumura T, Kabashima T, Kondo I, Yamane K, Sakurai T, Yamaguchi I, Kashiwagi H: Progressive systemic sclerosis with pancytopenia, polymyositis and complete heart block developing after D-penicilamine therapy: A case report (in Japanese). Nippon Naika Gakkai Zasshi 1985;74:959–963.
  10. Fudenberg H, Wintrobe MM: Scleroderma with symptomatic hemolytic anemia. Ann Intern Med 1955;43:201–206.
  11. Chaves FC, Rodrigo FG, Franco ML, Esteves J: Systemic sclerosis associated with auto-immune haemolytic anaemia. Br J Dermatol 1970;82:298–302.

    External Resources

  12. Rosenthal DS, Sack B: Autoimmune hemolytic anemia in scleroderma. JAMA 1971;216:2011–2012.
  13. Ivey KJ, Hwang Y, Sheets RF: Scleroderma associated with thrombocytopenia and Coombs-positive hemolytic anemia. Am J Med 1971;51:815–817.

    External Resources

  14. Jacobsen BB, Pedersen M, Herting SE: Generalized scleroderma. Report on a case associated with acute nephropathy, haemolytic anaemia and malignant ovarian tumour. Acta Med Scand 1972;192:107–111.

    External Resources

  15. Neucks SH, Moore TL, Lichtenstein JR, Baldassare AR, Weiss TD, Zuckner J: Localized scleroderma and idiopathic thrombocytopenia. J Rheumatol 1980;7:741–744.

    External Resources

  16. Waugh D, Ibels L: Malignant scleroderma associated with autoimmune neutropenia. Br Med J 1980;280:1577–1578.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00